{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:12:39Z","timestamp":1760202759827,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jvir.2017.07.032","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T09:31:00Z","timestamp":1505899860000},"page":"1681-1686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of Superficial Femoral Artery\u00a0Restenosis"],"prefix":"10.1016","volume":"28","author":[{"given":"Andrew J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin A.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin C.","family":"Mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5662-796X","authenticated-orcid":false,"given":"Sanjay","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2017.07.032_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0828-282X(09)70021-2","article-title":"Peripheral arterial disease: lack of awareness in Canada","volume":"25","author":"Lovell","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tcm.2016.02.007","article-title":"Endovascular treatment of lower extremity peripheral arterial disease","volume":"26","author":"Klein","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jvir.2017.07.032_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","article-title":"Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care","volume":"60","author":"Garimella","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvir.2017.07.032_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jvs.2010.01.062","article-title":"Endovascular interventions for TASC II D femoropopliteal lesions","volume":"51","author":"Baril","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib5","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0032-1331840","article-title":"An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors","volume":"22","author":"Shammas","year":"2013","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","article-title":"Classification and clinical impact of restenosis after femoropopliteal stenting","volume":"59","author":"Tosaka","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1148\/radiol.2361040084","article-title":"Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery\u2014the Vienna experience","volume":"236","author":"Wolfram","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2017.07.032_bib10","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in\u2013stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvir.2017.07.032_bib12","unstructured":"National Kidney Foundation. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. 2012. Available at: http:\/\/www.kdigo.org\/clinical_practice_guidelines\/pdf\/CKD\/KDIGO_2012_CKD_GL.pdf. Accessed August 29, 2017."},{"key":"10.1016\/j.jvir.2017.07.032_bib13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45 Suppl S","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib14","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1681\/ASN.V12122838","article-title":"Lower-extremity peripheral arterial disease among patients with end-stage renal disease","volume":"12","author":"O'Hare","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jvir.2017.07.032_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/157340309789317823","article-title":"Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review","volume":"5","author":"Kasapis","year":"2009","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jvir.2017.07.032_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1067\/msy.2000.108049","article-title":"Is lower extremity revascularization worthwhile in patients with end-stage renal disease?","volume":"128","author":"Korn","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.jvir.2017.07.032_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2215\/CJN.01070905","article-title":"Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease","volume":"1","author":"O'Hare","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jvir.2017.07.032_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jvs.2015.02.051","article-title":"The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation","volume":"62","author":"Otte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jvs.2011.01.062","article-title":"Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization","volume":"53","author":"Willenberg","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3760\/cma.j.issn.0366-6999.20122294","article-title":"Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions","volume":"126","author":"Yin","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jvir.2017.07.032_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications","volume":"114","author":"Golomb","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2017.07.032_bib22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jvs.2007.01.024","article-title":"The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease","volume":"45","author":"Feringa","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jvs.2007.11.056","article-title":"Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia","volume":"47","author":"Schanzer","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival rates in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S76651","article-title":"Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease","volume":"11","author":"Chen","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jvir.2017.07.032_bib26","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.jacc.2004.06.077","article-title":"The year in atherothrombosis","volume":"44","author":"Moreno","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.amjopharm.2006.12.006","article-title":"Peripheral arterial disease: a review of disease awareness and management","volume":"4","author":"Watson","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jvir.2017.07.032_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","article-title":"Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality","volume":"39","author":"Henke","year":"2004","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jvs.2003.12.027","article-title":"Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts","volume":"39","author":"Abbruzzese","year":"2004","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvir.2017.07.032_bib30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jvir.2016.05.037","article-title":"The influence of statin therapy on restenosis in patients who underwent nitinol stent implantation for de novo femoropopliteal artery disease: two-year follow-up at a single center","volume":"27","author":"Kim","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2017.07.032_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCULATIONAHA.111.033886","article-title":"Medical therapy in peripheral artery disease","volume":"126","author":"Berger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jvir.2017.07.032_bib32","first-page":"289","article-title":"Risk reduction with clopidogrel in the management of peripheral arterial disease","volume":"3","author":"Nayak","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jvir.2017.07.032_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvir.2017.07.032_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1148\/radiology.191.3.8184053","article-title":"Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up","volume":"191","author":"Matsi","year":"1994","journal-title":"Radiology"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104431730742X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104431730742X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T03:04:29Z","timestamp":1719457469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105104431730742X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S105104431730742X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2017.07.032","relation":{},"ISSN":["1051-0443"],"issn-type":[{"type":"print","value":"1051-0443"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Superficial Femoral Artery\u00a0Restenosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2017.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR 2017","name":"copyright","label":"Copyright"}]}}